{
  "drug_name": "Raltegravir",
  "url": "https://wikem.org/wiki/Raltegravir",
  "scraped_at": "2026-01-10T08:01:08.680706",
  "sections": {
    "Administration": {
      "text": "Type: Antiretroviral, Integrase inhibitor\nDosage Forms: 400 mg, 600 mg tablet\nRoutes of Administration: PO\nCommon Trade Names: Isentress",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adult_Dosing": {
      "text": "Recommended as part of a regimen including Tenofovir plus Emtricitabine or Lamivudine\nTreatment-naive: 400 mg BID or 1200 mg daily\nTreatment-experienced: 400 mg BID",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "Oral suspension (10 mg/mL): 6 mg/kg/dose BID\nMaximum dose: 100 mg/dose",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk: Unknown",
      "subsections": {
        "Renal_Dosing": {
          "text": "Mild to Moderate renal disease: No dosage adjustment necessary\nESRD on HD: Dose after dialysis on dialysis days",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "No dosage adjustment necessary",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_pregnancy_categories"
        }
      ]
    },
    "Renal_Dosing": {
      "text": "Mild to Moderate renal disease: No dosage adjustment necessary\nESRD on HD: Dose after dialysis on dialysis days",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "No dosage adjustment necessary",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "No dosage adjustment necessary",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Stevens-Johnson Syndrome\nAnaphylaxis\nMyopathy/\nRhabdomyolysis",
          "tables": []
        },
        "Common": {
          "text": "Hepatic- increased transaminases",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Stevens-Johnson Syndrome",
          "url": "https://wikem.org/wiki/Stevens-Johnson_Syndrome"
        },
        {
          "text": "Rhabdomyolysis",
          "url": "https://wikem.org/wiki/Rhabdomyolysis"
        }
      ]
    },
    "Serious": {
      "text": "Stevens-Johnson Syndrome\nAnaphylaxis\nMyopathy/\nRhabdomyolysis",
      "subsections": {
        "Common": {
          "text": "Hepatic- increased transaminases",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Stevens-Johnson Syndrome",
          "url": "https://wikem.org/wiki/Stevens-Johnson_Syndrome"
        },
        {
          "text": "Rhabdomyolysis",
          "url": "https://wikem.org/wiki/Rhabdomyolysis"
        }
      ]
    },
    "Common": {
      "text": "Hepatic- increased transaminases",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 9 hours\nMetabolism: Hepatic glucuronidation\nExcretion: Renal",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Reverse transcriptase inhibitor",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "References": {
      "text": "https://www.uptodate.com/contents/raltegravir-drug-information?search=Raltegravir&source=search_result&selectedTitle=1~42&usage_type=default&display_rank=1#F5374911",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}